You are here

  • Home
  • Archive
  • Volume 20, Issue 2
  • Randomized Phase II Trial of Paclitaxel Plus Carboplatin Therapy Versus Irinotecan Plus Cisplatin Therapy as First-Line Chemotherapy for Clear Cell Adenocarcinoma of the Ovary: A JGOG Study

Citation Tools

Article menu
Download PDFPDF
Ovarian Cancer
Randomized Phase II Trial of Paclitaxel Plus Carboplatin Therapy Versus Irinotecan Plus Cisplatin Therapy as First-Line Chemotherapy for Clear Cell Adenocarcinoma of the Ovary: A JGOG Study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Takakura S, Takano M, Takahashi F, et al
Randomized Phase II Trial of Paclitaxel Plus Carboplatin Therapy Versus Irinotecan Plus Cisplatin Therapy as First-Line Chemotherapy for Clear Cell Adenocarcinoma of the Ovary: A JGOG Study
International Journal of Gynecologic Cancer 2010;20:240-247.